NCT06726174View on ClinicalTrials.gov

Cell Therapy for Corneal Endothelial Cell Dysfunction

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 25, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Corneal Endothelial Cell Dysfunction
Interventions
DRUG

ECCEC

0.5-1x10\^6 cells/300 uL, intracameral injection.

Trial Locations (1)

100225

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER